CLEA Japan Conference Presentation Archive：SDT fatty/Jcl
24th The International Society of Nephrology (ISN), 9th World Congress of Nephrology (WCN) 2017 (April 21-25): Mexico City, Mexico.

2017/04/17

CLEA Japan Conference Presentation Archive：SDT fatty/Jcl<br/>24th The International Society of Nephrology (ISN), 9th World Congress of Nephrology (WCN) 2017 (April 21-25): Mexico City, Mexico.

10-week, but not 7-week, Dapagliflozin Treatment Improves Severe Renal Impairment in the Uni-nephrectomized SDT fatty rat, a 10-week Model of Advanced Renal Complications and Glomerular Filtration Rate Decline.

Key Word:
Dapagliflozin（ダパグリフロジン）、Renal Impairment（腎障害）、Uni-nephrectomized（片腎摘出）、Renal Complications（腎合併症）、Glomerular Filtration Rate（糸球体濾過速度(GFR)）、hypertensive, obese, type 2 diabetic model（高血圧、肥満、2型糖尿病モデル）

François Briand¹, Masami Shinohara², Emmanuel Brousseau¹, Takeshi Ohta³, Yasushi Kageyama², Thierry Sulpice¹

¹Physiogenex, Labège, France; ²CLEA Japan Inc. Meguro-ku, Tokyo, Japan, ³Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan

For more details, please click here (Google Search)